This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Innovative Scientific Products, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Glenn Fredrickson: Innovator in Pharmaceutical Container Technology
Introduction
Glenn Fredrickson is a notable inventor based in Santa Barbara, CA (US), recognized for his contributions to pharmaceutical container technology. With a total of 3 patents to his name, Fredrickson has made significant advancements in the field, particularly through innovative designs that enhance the functionality and safety of pharmaceutical containers.
Latest Patents
Fredrickson's latest patents include a groundbreaking pharmaceutical container featuring a pH protective layer deposited by atomic layer deposition. This invention comprises a lumen defined in part by a wall, which has an interior surface facing the lumen and an outer surface. The coating set on the interior surface includes a pH protective layer, applied using atomic layer deposition, ensuring the integrity of the pharmaceutical contents.
Career Highlights
Throughout his career, Glenn Fredrickson has been associated with Innovative Scientific Products, Inc., where he has played a pivotal role in developing advanced pharmaceutical solutions. His work has not only contributed to the company's success but has also set new standards in the industry.
Collaborations
Fredrickson has collaborated with esteemed colleagues such as Robert Abrams and Alexander Klibanov, further enhancing the innovative capabilities of his projects. These collaborations have fostered a creative environment that encourages the development of cutting-edge technologies.
Conclusion
In summary, Glenn Fredrickson is a distinguished inventor whose work in pharmaceutical container technology has led to significant advancements in the field. His innovative patents and collaborations reflect his commitment to improving pharmaceutical safety and efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile